查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2044300

情緒平衡消費品市場預測至2034年－按產品類型、成分類型、應用、通路、最終用戶和地區分類的全球分析

Emotional Balance Consumer Goods Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Application, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球「情緒平衡」消費品市場預計將在 2026 年達到 38 億美元，並在預測期內以 9.0% 的複合年成長率成長，到 2034 年達到 76 億美元。

「情緒平衡消費品」指的是一大類快速日常消費品（FMCG）和健康產品，其主要設計目的是透過營養、感官、技術和行為介入機制，作為輔助工具來支持心理和情緒調節、情緒穩定和心理健康。此類別包括：改善情緒的適應原補充劑、含有益智和情緒健康成分的功能性零食和飲料、針對邊緣系統情緒處理的芳香療法產品、壓力緩解和情緒健康套裝，以及用於監測情緒生理生物標記的穿戴式生物感測器。這些產品利用神經科學、心理神經免疫學和傳統植物醫學，以易於大眾接受的方式為消費者提供情緒健康支持。

對心理健康的認知不斷提高，情緒健康理念也日益普及。

圍繞著心理健康話題的巨大污名，以及消費者日益接受積極主動的情緒健康管理，並將其視為與身體健身同等重要的日常自我護理方式，正在從根本上改變消費者的購買趨勢，使其轉向能夠帶來情緒健康益處的產品。社群媒體主導的心理健康意識宣傳活動、名人代言的情緒健康產品，以及醫療保健系統在心理健康服務取得方面的局限性，都在促使消費者主動投資於情緒健康產品。這種消費行為的結構性轉變催生了一個全新的、規模龐大的品類，其中功能性營養、個人護理和健康科技相互交融。

對心理健康產品的有效性持懷疑態度，並對其安全性表示擔憂。

消費者和醫療保健提供者對消費品能否在不進行臨床干預的情況下帶來顯著的情緒健康效果持懷疑態度，這給情緒平衡產品品牌的信譽度構成了障礙。在缺乏嚴格臨床支持的情況下過度承諾情緒健康效果，可能會導致消費者失望、負面評價，以及監管機構針對未經證實的改善情緒聲明採取的行動。鑑於心理健康消費市場的敏感性，謹慎管理宣傳內容至關重要，以避免淡化嚴重的情緒障礙，或暗示消費品可以取代臨床心理健康治療。

在職場開展情緒健康計劃

隨著職業倦怠、焦慮和心理健康相關生產力下降問題的日益嚴重，企業加大對提升員工情緒健康和心理安全感項目的投入，為促進情緒平衡的消費品創造了巨大的B2B採購機會。雇主主導的情緒健康福利方案，例如包含適應原補充劑訂閱、感官壓力緩解產品套裝和情緒監測穿戴式裝置等，為企業通路開發擴充性的管道提供了契機。政府職業安全與健康法規日益重視心理安全要求，也促使企業出於合規主導加強對情緒健康的投入。

健康與心理健康治療之間的監管界限

聲稱有助於情緒平衡的消費者保健產品與受監管的醫療設備和精神疾病藥物治療之間的監管界限，給情緒平衡產品品牌帶來了持續的合規風險。多個主要市場的監管機構正在加強對那些明確聲稱能夠改善或調節情緒，但缺乏符合藥品標準的臨床試驗支持的產品的審查。被認定為做出核准的藥品功效聲明的產品，可能面臨強制性成分變更、召回風險以及巨額監管處罰，這給與情緒平衡相關的消費品類別帶來了巨大的商業風險。

新型冠狀病毒（COVID-19）的影響：

疫情引發了一場全球性的心理健康危機，前所未有的悲傷、焦慮、孤獨、經濟壓力和不確定性，大大提升了消費者對無需處方箋或專業諮詢即可獲得的心理健康解決方案的需求。在疫情期間，許多先前從未服用過保健品的消費者開始使用適應原、芳香療法和情緒調節補充劑等心理健康產品，這種轉變導致了消費者購買行為的持續變化，並在疫情結束後仍在延續。隨著後疫情時代人們對心理健康的日益關注，心理健康已在主要消費品類別中永久地重新定位為優先事項。

在預測期內，健康穿戴裝置領域預計將佔據最大的市場佔有率。

在預測期內，健康穿戴裝置預計將佔據最大的市場佔有率。這主要歸功於生物辨識心理健康監測設備的高階產品價值、深度用戶互動以及訂閱收入潛力。這些設備能夠提供可量化的情緒狀態數據和個人化的介入建議。消費者對使用具備心率變異性、皮膚電活動和皮質醇生物標記監測功能的穿戴式設備進行客觀心理健康追蹤的興趣，反映出消費者對超越主觀自我報告的、基於實證的心理健康管理工具的需求日益成長。

預計在預測期內，適應原市場區隔將呈現最高的複合年成長率。

在預測期內，適應原細分市場預計將呈現最高的成長率，這主要得益於大量臨床文獻的快速成長，這些文獻支持睡茄、紅景天、里昂塞拉塔和靈芝透過調節下視丘-腦下垂體-腎上腺軸（HPA軸）和支持腦源性神經營養因子（BDNF）來改善情緒健康的功效。這些功效引起了注重健康、重視科學方法的消費者的共鳴。適應原補充劑透過大型連鎖藥局、食品零售商和D2C（直接面對消費者）平台滲透到一般零售市場，顯著提高了全球消費者對適應原品類的認知度和接受度。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這得益於其全球領先的心理健康意識和消費者在情緒健康方面的支出、對情緒健康產品品牌的強勁創業投資投資，以及支持消費者發現情緒平衡產品的先進專業健康零售管道。美國憑藉其具有影響力的心理健康意識文化、主流健康媒體對情緒健康產品教育的投入，以及大規模的適應原補充劑消費群，引領其他地區。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要歸功於韓國、日本、中國和印度等國對心理健康的討論迅速轉變，這些國家長期以來對心理健康有偏見，如今已逐漸被主流社會所接受。此外，根深蒂固的傳統植物來源情緒療法文化也提升了消費者對適應性情緒支持產品的認知。同時，政府的心理健康投資計畫也催生了對整合情緒健康產品的機構需求。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球情緒平衡消費品市場：依產品類型分類

  • 改善情緒的補充劑
  • 功能性零食和飲料
  • 芳香療法產品
  • 減壓套裝
  • 健康穿戴裝置

第6章：全球情緒平衡消費品市場：依成分類型分類

  • 適應原
  • 益智藥
  • 植物萃取物
  • 維生素和礦物質
  • 益生菌

第7章：全球情緒平衡消費品市場：依應用領域分類

  • 壓力管理
  • 情緒改善
  • 睡眠改善
  • 緩解焦慮
  • 認知支持

第8章：全球情緒平衡消費品市場：依通路分類

  • 電子商務
  • 零售店
  • 藥局
  • 健康專賣店
  • 健身中心

第9章：全球情緒平衡消費品市場：依最終用戶分類

  • 成人
  • 青少年
  • 老年人
  • 致所有職場人士
  • 健身愛好者

第10章：全球情緒平衡消費品市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Nestle SA
  • Danone SA
  • PepsiCo Inc.
  • The Coca-Cola Company
  • Herbalife Nutrition Ltd.
  • Amway Corporation
  • GSK plc
  • Bayer AG
  • Pfizer Inc.
  • Unilever PLC
  • Procter & Gamble Co.
  • Reckitt Benckiser Group
  • Haleon plc
  • Blackmores Limited
  • Nature's Way Products LLC
  • Now Health Group Inc.
  • Garden of Life
Product Code: SMRC36089

According to Stratistics MRC, the Global Emotional Balance Consumer Goods Market is accounted for $3.8 billion in 2026 and is expected to reach $7.6 billion by 2034 growing at a CAGR of 9.0% during the forecast period. Emotional balance consumer goods refer to a broadly defined category of FMCG and wellness products engineered with the primary therapeutic intent of supporting psychological and emotional regulation, mood stabilization, and mental well-being through nutritional, sensory, technological, and behavioral intervention mechanisms. This category encompasses mood-enhancing adaptogenic supplements, functional snacks and beverages delivering nootropic and emotional wellness actives, aromatherapy product ranges targeting limbic system emotional processing, stress relief, and emotional wellness kit bundles, and wearable biosensing devices monitoring emotional physiological biomarkers. Products draw on neuroscience, psychoneuroimmunology, and traditional botanical medicine to deliver commercially accessible emotional wellness support.

Market Dynamics:

Driver:

Mental health awareness and emotional wellness consumerization

Dramatic destigmatization of mental health discussions, combined with growing consumer acceptance of proactive emotional wellness management as a daily self-care priority equivalent to physical fitness, is fundamentally reshaping consumer goods purchasing toward products delivering emotional wellbeing benefits. Social media-driven mental health awareness advocacy, celebrity endorsement of emotional wellness products, and healthcare system mental health access limitations are collectively driving consumer investment in self-directed emotional wellness product solutions. This structural consumer behavior shift has created a new mega-category at the intersection of functional nutrition, personal care, and wellness technology.

Restraint:

Mental health product efficacy skepticism, and safety concerns

Consumer and healthcare provider skepticism regarding the ability of consumer goods products to deliver meaningful emotional wellness benefits without clinical-grade intervention creates credibility barriers for emotional balance product brands. Over-promising emotional wellness outcomes without rigorous clinical substantiation risks generating consumer disappointment, negative reviews, and regulatory enforcement actions targeting unsubstantiated mood enhancement claims. The sensitivity of mental health consumer markets requires careful claim management to avoid trivializing serious emotional disorders or suggesting that consumer products substitute for clinical mental health treatment.

Opportunity:

Workplace emotional wellness program development

Corporate investment in workforce emotional health and psychological safety programs driven by escalating burnout, anxiety, and mental health-related productivity losses is creating substantial B2B procurement opportunities for emotional balance consumer goods. Employer emotional wellness benefit packages incorporating adaptogenic supplement subscriptions, sensory stress relief product kits, and emotional monitoring wearables represent scalable enterprise channel development opportunities. Government occupational health and safety regulations increasingly incorporating psychological safety requirements are creating compliance-driven corporate emotional wellness investment.

Threat:

Regulatory boundary between wellness and mental health treatment

The regulatory boundary between consumer wellness products making emotional balance support claims and regulated medical devices or pharmaceutical treatments for mental health disorders creates ongoing compliance risk for emotional balance product brands. Regulatory agencies in multiple major markets are increasing scrutiny of products making explicit mood improvement and emotional regulation claims without clinical trial substantiation meeting pharmaceutical-equivalent standards. Products deemed to be making unapproved drug claims face mandatory reformulation, recall risk, and substantial regulatory penalty exposure that creates material business risk for the emotional balance consumer goods category.

Covid-19 Impact:

The pandemic triggered a global emotional health crisis through unprecedented grief, anxiety, loneliness, economic stress, and uncertainty that profoundly elevated consumer demand for accessible emotional wellness interventions available without prescription or professional consultation. Pandemic-period adoption of emotional wellness products, including adaptogens, aromatherapy, and mood-support supplements by previously non-supplement consumers created durable purchase behavior change that has outlasted the pandemic period. Post-pandemic mental health awareness elevation has permanently repositioned emotional wellness as a mainstream consumer goods category priority.

The Wellness Wearables segment is expected to be the largest during the forecast period

The Wellness Wearables segment is expected to account for the largest market share during the forecast period, due to the premium product value, consumer engagement depth, and subscription revenue potential of biometric emotional wellness monitoring devices that provide quantifiable emotional state data and personalized intervention recommendations. Consumer appetite for objective emotional health tracking using heart rate variability, electrodermal activity, and cortisol biomarker monitoring wearables reflects growing demand for evidence-based emotional wellness management tools beyond subjective self-reporting.

The Adaptogens segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Adaptogens segment is predicted to witness the highest growth rate, driven by rapidly expanding clinical literature validating ashwagandha, rhodiola, lion's mane, and reishi mushroom emotional wellness benefits through HPA axis modulation and BDNF neurotrophic factor support mechanisms that resonate with scientifically-oriented wellness consumers. Mainstream retail penetration of adaptogenic supplements through major pharmacy chains, grocery retailers, and direct-to-consumer platforms is substantially increasing adaptogen category consumer awareness and trial rates globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the highest global mental health awareness and emotional wellness consumer spending, strong venture capital investment in emotional wellness product brands, and advanced specialty wellness retail channels supporting emotional balance product discovery. The United States leads with influential mental health advocacy culture, major wellness media investment in emotional wellness product education, and large adaptogenic supplement consumer base.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to dramatically growing mental health awareness in South Korea, Japan, China, and India where historically stigmatized mental wellness conversations are rapidly shifting toward mainstream acceptance, combined with strong traditional botanical emotional wellness remedy cultures providing consumer familiarity with adaptogenic emotional support products. Government mental health investment programs are creating institutional demand for emotional wellness product integration.

Key players in the market

Some of the key players in Emotional Balance Consumer Goods Market include Nestle S.A., Danone S.A., PepsiCo Inc., The Coca-Cola Company, Herbalife Nutrition Ltd., Amway Corporation, GSK plc, Bayer AG, Pfizer Inc., Unilever PLC, Procter & Gamble Co., Reckitt Benckiser Group, Haleon plc, Blackmores Limited, Nature's Way Products LLC, Now Health Group Inc., and Garden of Life.

Key Developments:

In April 2026, Garden of Life launched a whole-food adaptogenic mood support supplement range featuring certified organic ashwagandha, lion's mane, and saffron with clinical documentation of emotional well-being improvement.

In March 2026, Haleon plc introduced an emotional wellness supplement line combining magnesium glycinate, L-theanine, and rhodiola for daily stress resilience and mood stability support.

In February 2026, Nature's Way Products LLC released a comprehensive emotional balance kit bundling adaptogenic tinctures, mood-supporting aromatherapy, and a biosensing wellness tracker for integrated emotional health management.

Product Types Covered:

  • Mood-Enhancing Supplements
  • Functional Snacks & Beverages
  • Aromatherapy Products
  • Stress Relief Kits
  • Wellness Wearables

Ingredient Types Covered:

  • Adaptogens
  • Nootropics
  • Botanical Extracts
  • Vitamins & Minerals
  • Probiotics

Applications Covered:

  • Stress Management
  • Mood Enhancement
  • Sleep Improvement
  • Anxiety Reduction
  • Cognitive Support

Distribution Channels Covered:

  • E-Commerce
  • Retail Stores
  • Pharmacies
  • Specialty Wellness Stores
  • Fitness Centers

End Users Covered:

  • Adults
  • Teenagers
  • Geriatric Population
  • Working Professionals
  • Fitness Enthusiasts

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Emotional Balance Consumer Goods Market, By Product Type

  • 5.1 Mood-Enhancing Supplements
  • 5.2 Functional Snacks & Beverages
  • 5.3 Aromatherapy Products
  • 5.4 Stress Relief Kits
  • 5.5 Wellness Wearables

6 Global Emotional Balance Consumer Goods Market, By Ingredient Type

  • 6.1 Adaptogens
  • 6.2 Nootropics
  • 6.3 Botanical Extracts
  • 6.4 Vitamins & Minerals
  • 6.5 Probiotics

7 Global Emotional Balance Consumer Goods Market, By Application

  • 7.1 Stress Management
  • 7.2 Mood Enhancement
  • 7.3 Sleep Improvement
  • 7.4 Anxiety Reduction
  • 7.5 Cognitive Support

8 Global Emotional Balance Consumer Goods Market, By Distribution Channel

  • 8.1 E-Commerce
  • 8.2 Retail Stores
  • 8.3 Pharmacies
  • 8.4 Specialty Wellness Stores
  • 8.5 Fitness Centers

9 Global Emotional Balance Consumer Goods Market, By End User

  • 9.1 Adults
  • 9.2 Teenagers
  • 9.3 Geriatric Population
  • 9.4 Working Professionals
  • 9.5 Fitness Enthusiasts

10 Global Emotional Balance Consumer Goods Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Nestle S.A.
  • 13.2 Danone S.A.
  • 13.3 PepsiCo Inc.
  • 13.4 The Coca-Cola Company
  • 13.5 Herbalife Nutrition Ltd.
  • 13.6 Amway Corporation
  • 13.7 GSK plc
  • 13.8 Bayer AG
  • 13.9 Pfizer Inc.
  • 13.10 Unilever PLC
  • 13.11 Procter & Gamble Co.
  • 13.12 Reckitt Benckiser Group
  • 13.13 Haleon plc
  • 13.14 Blackmores Limited
  • 13.15 Nature's Way Products LLC
  • 13.16 Now Health Group Inc.
  • 13.17 Garden of Life

List of Tables

  • Table 1 Global Emotional Balance Consumer Goods Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Emotional Balance Consumer Goods Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Emotional Balance Consumer Goods Market Outlook, By Mood-Enhancing Supplements (2023-2034) ($MN)
  • Table 4 Global Emotional Balance Consumer Goods Market Outlook, By Functional Snacks & Beverages (2023-2034) ($MN)
  • Table 5 Global Emotional Balance Consumer Goods Market Outlook, By Aromatherapy Products (2023-2034) ($MN)
  • Table 6 Global Emotional Balance Consumer Goods Market Outlook, By Stress Relief Kits (2023-2034) ($MN)
  • Table 7 Global Emotional Balance Consumer Goods Market Outlook, By Wellness Wearables (2023-2034) ($MN)
  • Table 8 Global Emotional Balance Consumer Goods Market Outlook, By Ingredient Type (2023-2034) ($MN)
  • Table 9 Global Emotional Balance Consumer Goods Market Outlook, By Adaptogens (2023-2034) ($MN)
  • Table 10 Global Emotional Balance Consumer Goods Market Outlook, By Nootropics (2023-2034) ($MN)
  • Table 11 Global Emotional Balance Consumer Goods Market Outlook, By Botanical Extracts (2023-2034) ($MN)
  • Table 12 Global Emotional Balance Consumer Goods Market Outlook, By Vitamins & Minerals (2023-2034) ($MN)
  • Table 13 Global Emotional Balance Consumer Goods Market Outlook, By Probiotics (2023-2034) ($MN)
  • Table 14 Global Emotional Balance Consumer Goods Market Outlook, By Application (2023-2034) ($MN)
  • Table 15 Global Emotional Balance Consumer Goods Market Outlook, By Stress Management (2023-2034) ($MN)
  • Table 16 Global Emotional Balance Consumer Goods Market Outlook, By Mood Enhancement (2023-2034) ($MN)
  • Table 17 Global Emotional Balance Consumer Goods Market Outlook, By Sleep Improvement (2023-2034) ($MN)
  • Table 18 Global Emotional Balance Consumer Goods Market Outlook, By Anxiety Reduction (2023-2034) ($MN)
  • Table 19 Global Emotional Balance Consumer Goods Market Outlook, By Cognitive Support (2023-2034) ($MN)
  • Table 20 Global Emotional Balance Consumer Goods Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 21 Global Emotional Balance Consumer Goods Market Outlook, By E-Commerce (2023-2034) ($MN)
  • Table 22 Global Emotional Balance Consumer Goods Market Outlook, By Retail Stores (2023-2034) ($MN)
  • Table 23 Global Emotional Balance Consumer Goods Market Outlook, By Pharmacies (2023-2034) ($MN)
  • Table 24 Global Emotional Balance Consumer Goods Market Outlook, By Specialty Wellness Stores (2023-2034) ($MN)
  • Table 25 Global Emotional Balance Consumer Goods Market Outlook, By Fitness Centers (2023-2034) ($MN)
  • Table 26 Global Emotional Balance Consumer Goods Market Outlook, By End User (2023-2034) ($MN)
  • Table 27 Global Emotional Balance Consumer Goods Market Outlook, By Adults (2023-2034) ($MN)
  • Table 28 Global Emotional Balance Consumer Goods Market Outlook, By Teenagers (2023-2034) ($MN)
  • Table 29 Global Emotional Balance Consumer Goods Market Outlook, By Geriatric Population (2023-2034) ($MN)
  • Table 30 Global Emotional Balance Consumer Goods Market Outlook, By Working Professionals (2023-2034) ($MN)
  • Table 31 Global Emotional Balance Consumer Goods Market Outlook, By Fitness Enthusiasts (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.